서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 34 of 34

Issue DateTitle / Author(s) / CitationFileAltmetrics
2004-12
Feature genes of hepatitis B virus-positive hepatocellular carcinoma, established by its molecular discrimination approach using prediction analysis of microarray
DOI
2009-10
Malignant Mesothelioma in Body Fluids - with Special Reference to Differential Diagnosis from Metastatic Adenocarcinoma

Paik, Jin Ho; Chung, Jin-Haeng; Kim, Baek-Hui; Choe, Gheeyoung

Korean Journal of Pathology, Vol.43 No.5, pp.458-466

DOI
2011-03
Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: Correlation with fluorescence in situ hybridization
DOI
2011-03
Otologic manifestation in IgG4-related systemic disease

Cho, Han-Kyu; Lee, Yun Jong; Chung, Jin-Haeng; Koo, Ja-Won

Clinical and Experimental Otorhinolaryngology, Vol.4 No.1, pp.52-54

DOI
2011-05
Otologic Manifestation in IgG4-Related Systemic Disease

Cho, Han-Kyu; Lee, Yun Jong; Chung, Jin-Haeng; Koo, Ja-Won

Clinical and Experimental Otorhinolaryngology Vol.4 No.1, pp. 52-54

view fileDOI
2011-08
Detection of ALK gene rearrangement in non-small cell lung cancer: A comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression
DOI
2012-04
Liquid-Based Cytology of Villoglandular Adenocarcinoma of the Cervix: A Report of 3 Cases
DOI
2012-06
Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer A proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma
DOI
2012-11
The association of down-regulated toll-like receptor 4 expression with airflow limitation and emphysema in smokers
DOI
2013-01
Discordance between anaplastic lymphoma kinase status in primary non-small-cell lung cancers and their corresponding metastases
DOI
2013-10
A Comprehensive Comparative Analysis of the Histomorphological Features of ALK-Rearranged Lung Adenocarcinoma Based on Driver Oncogene Mutations: Frequent Expression of Epithelial-Mesenchymal Transition Markers than Other Genotype
DOI
2017-01
MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status
DOI
2017-02
The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases
DOI
2017-05
Molecular Testing of Lung Cancers
DOI
2017-05
Comparison of Prognosis of Solid and Part-Solid Node-Negative Adenocarcinoma With the Same Invasive Component Size
DOI
2017-08
Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement
DOI
2017-09
Clinicopathologic implications of the miR-197/PD-L1 axis in oral squamous cell carcinoma
DOI
2017-11
PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study
DOI
2018-02
Interobserver variation among pathologists and refinement of criteria in distinguishing separate primary tumors from intrapulmonary metastases in lung
DOI
2018-03
Efficacy of pemetrexed-based chemotherapy in comparison to non-pemetrexed-based chemotherapy in advanced, ALK plus non-small cell lung cancer
view fileDOI
2018-03
Osteosarcomatous differentiation in rebiopsy specimens of pulmonary adenocarcinoma with EGFR-TKI resistance

Ahn, Hyein; Kwon, Hyun Jung; Park, Eunhyang; Kim, Hyojin; Chung, Jin-Haeng

Journal of Pathology and Translational Medicine, Vol.52 No.2, pp.130-132

DOI
2018-04
Pathological prognostic factors of recurrence in early stage lung adenocarcinoma

Yi, Eunjue; Bae, Mi-Kyeong; Cho, Sukki; Chung, Jin-Haeng; Jheon, Sanghoon; Kim, Kwhanmien

ANZ Journal of Surgery, Vol.88 No.4, pp.327-331

DOI
2018-09
Potential oncogenic role and prognostic implication of microRNA-155-5p in oral squamous cell carcinoma

Kim, Hyojin; Yang, Jeong Mi; Ahn, Soon-Hyun; Jeong, Woo-Jin; Chung, Jin-Haeng; Paik, Jin Ho

Anticancer Research, Vol.38 No.9, pp.5193-5200

DOI
2019-01
Epidermal growth factor receptor gene amplification predicts worse outcome in patients with surgically resected nonadenocarcinoma lung cancer

Chang, Hyun; Yang, Yaewon; Lee, Jong-Seok; Jheon, Sang-Hoon; Kim, Yu Jung; Chung, Jin-Haeng

Clinical Lung Cancer, Vol.20 No.1, pp.7-12.e1

DOI
2020-06
Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma
DOI
2021-03
Tumor LAG-3 and NY-ESO-1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non-small cell lung cancer
DOI
2021-10
Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening
DOI
2022-03
Artificial Intelligence-Powered Analyzer Reduces Inter-observer Variation in PD-L1 Tumor Proportion Score of Non-Small Cell Lung Cancer
2022-04
Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
DOI
2022-05
Expression-based species deconvolution and realignment removes misalignment error in multispecies single-cell data
DOI
2022-06
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer
DOI
2022-09
Landscape of EGFR mutations in lung adenocarcinoma: a single institute experience with comparison of PANAMutyper testing and targeted next-generation sequencing

Lee, Jeonghyo; Han, Yeon Bi; Kwon, Hyun Jung; Lee, Song Kook; Kim, Hyojin; Chung, Jin-Haeng

Journal of Pathology and Translational Medicine, Vol.56 No.5, pp.249-259

DOI
2022-12
Mitochondrial double-stranded RNAs as a pivotal mediator in the pathogenesis of Sjӧgrens syndrome
DOI
2024-02
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types
DOI
1